PREdiction of Survival on ECMO Therapy (PRESET) Score
Why Use
Offers a structured, evidence-based approach to estimating mortality risk in ECMO candidates and helps guide discussions on prognosis. Facilitates more standardized triage decisions and resource allocation. Unlike many similar ECMO risk scores, this tool relies exclusively on extrapulmonary variables in its risk assessment.
When to Use
Consider using in critically ill patients with acute respiratory distress syndrome (ARDS) who are candidates for veno-venous ECMO to help assess their likelihood of survival on ECMO.
Formula
Pearls / Pitfalls
Derived from data on 108 adult patients with ARDS on veno-venous ECMO (all using an identical ECMO system) at a single center; application to other patient groups or different ECMO systems may affect accuracy. In the derivation study, this tool outperformed several similar scores (e.g., ECMOnet, RESP Score , PRESERVE Score, Roch Score) in predicting mortality. Interestingly, respiratory variables were not found to predict survival in the development of this score. This tool provides an estimate of in-hospital survival and does not address long-term survival, quality of life, or disability.
Advice
Use the results of this tool in conjunction with other clinical parameters and specialist expertise—no single score should be the sole determinant for ECMO candidacy. Incorporate results into ECMO therapy planning if the patient is otherwise a suitable candidate, and engage in goals-of-care conversations that include therapy limitations, alternative salvage interventions, and palliative care options.
More Information
Interpretation: PRESET Score Risk Class ICU Mortality 0-5 Class I 26% 6-9 Class II 68% 10-15 Class III 93% From Hilder 2017 .